Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled trial of thalidomide for CGD-associated colitis
jRCT2031200236Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic granulomatous disease (CGD) comparing Thalidomide arm with Placebo arm (2 arms). Started Sep 2017; status: completed.
02
Drugs
thalidomide
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on jRCT2031200236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200236.